Motivational Evaluation and Intervention With Co-Adapt Application for Healthy Ageing
1 other identifier
interventional
74
1 country
1
Brief Summary
The aim of this study is to identify effective methodologies to help people to improve their awareness of change, motivation, self-confidence and self-efficacy, compliance in behavioral change and psychological well-being.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 26, 2021
CompletedFirst Posted
Study publicly available on registry
November 11, 2021
CompletedStudy Start
First participant enrolled
November 11, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 20, 2022
CompletedJanuary 21, 2022
January 1, 2022
2 months
October 26, 2021
January 20, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in levels of General Self-Efficacy Scale-10 (GSE-10)
GSE-10 test is a validated test for the detection of general self efficacy. The total score ranges from 10 to 40. Higher scores mean better outcomes.
Up to day 14
Change in levels of Basic Psychological Need Satisfaction and Frustration Scale (BPNSFS)
The BPNSFP-24 test is a validated test for the detection of the satisfaction and frustration of the primary needs: autonomy, relatedness and competence (according to SDT Theory). The total score ranges from 24 to 120. Higher scores mean better outcomes.
Up to day 14
Secondary Outcomes (2)
Change of the scales contained in the Depression Anxiety Stress Scales-21 (DASS-21)
Up to day 14
Change in World Health Organisation-Five Well-Being Index (WHO-5)
Up to day 14
Study Arms (2)
SDT (MI)
ACTIVE COMPARATORThis group will receive standard 2 SDT (Self Determination Theory) psychological interviews.
SDT (MI) + CA
EXPERIMENTALThis group will receive standard 2 SDT (Self Determination Theory) psychological interviews; moreover they will use an APP with a CA (Conversational Agent), an Artificial Intelligence.
Interventions
Eligibility Criteria
You may qualify if:
- whitecollar
- a sufficient level of education to understand study procedures and be able to communicate with site personnel
- to 70 years old
You may not qualify if:
- \- current use of narcotics or other substances
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Idego srllead
Study Sites (1)
Idego srl
Rome, 00197, Italy
Study Officials
- PRINCIPAL INVESTIGATOR
Tommaso Ciulli
Idego srl
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 26, 2021
First Posted
November 11, 2021
Study Start
November 11, 2021
Primary Completion
December 31, 2021
Study Completion
January 20, 2022
Last Updated
January 21, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Data will be available starting in February 2022
- Access Criteria
- The data available on the research website (www.co-adapt.it). A special page will be created where researchers can download the raw data to perform any analysis.
Clinical data obtained from psychological testing and socio-demographic data and any feedback collected during the trial will be shared.